The ARR allele is considered to provide a very strong resistance against classical scrapie infection in sheep. In this study, we report the occurrence of clinical transmissible spongiform encephalopathy in ARR/ARR sheep, following their inoculation by the intracerebral route with a classical scrapie isolate. On first passage, the disease displayed an incomplete attack rate transmission, with incubation periods exceeding 6 years. On second passage, the obtained prion did not display better abilities to propagate than the original isolate. These transmission results contrasted with the 100 % attack rate and the short incubation periods observed in ARQ/ARQ sheep challenged with the same isolate. These data confirm that ARR/ARR sheep cannot be considered to be fully resistant to classical scrapie. However, they also support the contention that classical scrapie has a very limited capacity to transmit and adapt to ARR/ARR sheep.
Over the last 15 years, substantial breeding programs have been implemented within the European Union with the aim of increasing the frequency of the ARR allele in sheep populations within member states. The overall goal of these 'breeding for resistance policy' sheep breeding programmes has been to reduce the incidence of classical scrapie in sheep populations in order to prevent the entry of ovine prions into the food and feed chains. However, concerns have been raised about the potential consequences of this PrP-based genetic selection policy. For example, the possibility exists that as a result of an increased frequency of the ARR allele in sheep flocks there will be the emergence and/or adaptation of classical scrapie agent(s) within ARR/ARR animals. Epidemiological surveillance programs implemented conjointly with the breeding for resistance policy in the European Union did not identify classical scrapie cases in ARR/ ARR sheep [6] . However, at least three naturally occurring classical scrapie cases have been confirmed in ARR/ARR sheep [7] . More recently, PrP
Sc accumulation was reported in the central nervous system in 2 out of 20 ARR/ARR clinically silent sheep following intracerebral challenge with classical scrapie [8] . These findings indicate that potential transmission and adaptation of a TSE agent to homozygous ARR sheep requires further investigation.
In the study presented here, we have inoculated experimental groups of ARQ/ARQ (n=5) and ARR/ARR (n=10) TSEfree sheep by the intracerebral route with an ARQ/ARQ classical scrapie isolate (250 µl of 10 % brain homogenate). Sheep (Cheviot, Suffolk and Poll-Dorset) included in the experiment were aged between 12 and 24 months at the time they were inoculated. Inoculation was performed in the right temporal cortex, as previously described [9] . The inoculated sheep were from a flock housed within a biosecure unit, and were originally sourced from New Zealand by the Veterinary Laboratory Agency (now Animal and Plant Health Agency), Weybridge, UK, and considered free of classical scrapie [10] . The PRNP gene of each inoculated sheep was sequenced prior to experimental scrapie inoculation [11] . The scrapie isolate used here was prepared from the brainstem of an ARQ/ARQ sheep born in 1997 and raised in the INRA Langlade flock, where a natural scrapie has been epidemic for more than 15 years [12] .
Clinical signs compatible with ovine TSE disease were observed in 100 % of the scrapie-exposed ARQ/ARQ sheep after 329±5 days post-inoculation (p.i.). Clinical signs of ovine TSE were also observed in 4 out of 10 of the ARR/ ARR scrapie-inoculated sheep. The incubation period in the scrapie-inoculated ARR/ARR sheep ranged from 2377 to 3011 days p.i., i.e. over 7-to 9-fold longer than in the ARQ/ ARQ animals. Tissues collected in ARQ/ARQ and ARR/ ARR scrapie-inoculated sheep were investigated for abnormal PrP accumulation by immunohistochemistry (IHC) (anti-PrP mAb 8G8) and Western blot (anti-PrP mAb sha31), as previously described [13, 14] .
In both genotypes, IHC revealed PrP
Sc deposition in the brain and the skeletal muscles (muscle spindles) of clinically affected sheep. Strikingly, PrP
Sc was observed in the lymphoid organs of the scrapie-inoculated ARQ/ARQ sheep, but not in the ARR/ARR affected sheep. Among the 10 ARR/ARR scrapie-inoculated sheep, those that died from inter-current disease or natural death, or that were euthanized >2400 days p.i., did not show clinical signs of sheep TSE or any PrP Sc deposition in any of the investigated tissues that were examined by IHC and Western blot (see Table 1 ). These observations demonstrate that classical scrapie can be transmitted with an apparently limited efficacy to ARR/ARR sheep following intra-cerebral inoculation, which is similar to what is seen with cattle BSE [15] .
To assess whether primary passage of classical scrapie in ARR/ARR sheep resulted in adaptation of the transmissible agent within this particular host, a second passage by intracerebral inoculation was carried out in sheep of the same PrP genotype. The inoculum for this second passage was prepared using the posterior brain stem obtained from one of the clinically affected ARR/ARR sheep at first passage (sheep no. 9; Table 1 ). Among the second passage ARR/ARR scrapieinoculated sheep (n=5), three died from inter-current disease at 1052, 1247 and 1592 days p.i. IHC and Western blot revealed no detectable PrP Sc in the lymphoid organs or the brain of these animals. The two remaining second passage ARR/ARR scrapie-inoculated sheep developed clinical signs of ovine TSE disease at 1766 and 2053 days p.i. PrP
Sc accumulation was observed in the brain and the skeletal muscle (muscle spindles), but not in the lymphoid organs of these two clinically affected second passage animals.
In the Western blot, the banding pattern of the PKresistant PrP
Sc that accumulated in the brain of the first and second passage scrapie-inoculated ARQ/ARQ and ARR/ARR sheep was similar to that seen for the original isolate (Fig. 1a) . This was consistent with an absence of phenotypic change of the original transmissible prion moiety during transmission in ARR and ARQ homozygous sheep.
To confirm this, the original inoculum, and brain material obtained after propagation in one ARQ/ARQ (no. 1 in Table 1 ) and one ARR/ARR (no. 9 in Table 1 ) sheep were strain typed in tg338 mice, which express the VRQ ovine PrP genotype [16] . All three inocula induced mouse prion disease with a 100 % attack rate on first passage in tg338 Table 2) . The recorded incubation periods in tg338 mice were significantly longer in those animals inoculated with the ARR/ARR material compared to those inoculated with the original inoculum or the ARQ/ARQ sheep isolate. However, at second passage in tg338 mice, all three isolates induced murine prion disease with similar incubation periods. Moreover, PrP res Western blot profiles (Fig. 1b) and the vacuolar lesion profiles (established as described by Fraser and Dickinson) in the brain of the prion diseased tg338 mice (Fig. 1c, e) were invariant irrespective of the inoculum [14, 17] . These data are consistent with the view that the same prion strain was present in the original inoculum and the experimentally challenged ARQ/ARQ and ARR/ARR sheep.
The main objective of this study was to address the question of the potential adaptation (upon serial passage) of a classical scrapie prion to ARR/ARR sheep. The slight but consistent reduction of the incubation periods that we observed during the second passage in ARR/ARR sheep (compared with the first passage) could suggest an adaptation of the original prion to sheep bearing this genotype. However, the transmission rate on second passage remained incomplete (absence of detectable PrP Sc accumulation in tissues and clinical signs in three out of the five inoculated animals), which is not clearly indicative of an adaption of the prion to ARR/ARR sheep.
The need for up to four iterative passages into a new host before complete adaptation of a prion was described in rodent models [18] . However, these particular data were obtained in the context of interspecies transmission. Moreover, such progressive adaptation was generally associated with radical changes in the biological properties of the propagated prion (strain). This was clearly not the case in our study, where primary transmission was performed within the same host species (sheep) and the original prion strain properties were maintained after transmission.
A third passage would be helpful to definitively confirm the limited/lack of adaptation of the scrapie agent to ARR/ARR sheep. However, such an experiment would necessitate 3 to 6 years before completion.
Beyond this, the comparison between transmission features of the classical scrapie isolate in ARR/ARR and ARQ/ARQ sheep is also of interest. Even upon second passage in ARR/ ARR sheep, the transmission features (attack rate, incubation period, absence of PrP Sc accumulation in lymphoid organs) indicated the still poor abilities of the prion to propagate in ARR/ARR sheep in comparison with ARQ/ARQ sheep.
The successful transmission of a clinical scrapie to ARR/ ARR sheep could be considered as an indication of a substantially lower than believed resistance to classical scrapie infection in animals bearing this genotype. However, it would be ignoring the fact that the intracerebral challenge route is the most efficient transmission route for TSE agents and does not reflect natural exposure conditions [19] [20] [21] .
Studies carried out over more than 15 years in the flock of origin of the scrapie agent (INRA Langlade) that was used as the inoculum failed to identify any evidence of TSE infection or TSE agent carriage (occurrence of clinical disease/ PrP Sc deposition in tissues) in hundreds of ARR/ARR sheep naturally exposed to infection since their birth [1, 4, 12] . In addition, the data reported by Jeffrey et al. in ARR/ARR sheep experimentally challenged with classical scrapie by different routes concur with our observations: PrP Sc accumulation was detected in the central nervous system of some of the ARR/ARR sheep after intracerebral challenge, but not in the tissues of animals challenged by the oral or sub-cutaneous route [8] .
In conclusion, our data further confirm that ARR/ARR sheep cannot be considered to be fully resistant to classical scrapie. However, within the limit of the experiment (one tested scrapie isolate) they support the view that classical scrapie has limited capacity to propagate and to adapt to ARR/ARR sheep. These results strongly reinforce our confidence in the fact that 'breeding for resistance' is a safe and sustainable approach to control and eradicate classical scrapie in affected flocks and in general sheep population. A classical scrapie isolate was inoculated intracerebrally into ARQ/ARQ sheep (one passage) and ARR/ARR sheep. These samples were then inoculated (two iterative passages) by the intracerebral route into mice that expressed the ovine PrP (tg338). The sheep whose brain stem (10 % tissue homogenate) was used to inoculate the mice is identified in brackets (see also 
